NCT01694810View on ClinicalTrials.gov

Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Acne Vulgaris
Interventions
DRUG

2% NVN1000 Topical Gel

2% NVN1000 Topical Gel once daily for 4 weeks

DRUG

4% NVN1000 Topical Gel

4% NVN1000 4% Topical Gel applied once daily 4 weeks

DRUG

8% NVN1000 Topical Gel

8% NVN1000 Topical Gel applied once daily for 4 weeks

DRUG

Vehicle Topical Gel

Vehicle Topical Gel applied once daily

Trial Locations (1)

19008

KGL, Inc, Broomall

All Listed Sponsors
lead

Novan, Inc.

INDUSTRY

NCT01694810 - Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers | Biotech Hunter | Biotech Hunter